Study Finds That HPV Vaccine Reduces At Least 87% Of Cervical Cancer In Women

Deseret News

According to the Cleveland Clinic website, ‘Approximately 79 million Americans are currently infected with HPV, with roughly 14 million people becoming newly infected each year.’

With such staggering statistics, it’s no wonder that people are so grateful that the risk of getting the HPV virus, otherwise known as the human papillomavirus, can be lessened through the use of the HPV vaccine. A new study has confirmed that the vaccine has so far managed to reduce cervical cancer rates by an astonishing 87% in females that were inoculated between the ages of 12 to 13.

A research group from King’s College London discovered that the HPV vaccination program managed to prevent around 450 cervical cancers, and another 17,200 pre-cancers by the middle of the year 2019.

The study also discovered that the cervical cancer rates were lessened by at least 62% in females that were given the vaccine between the ages of 14 to 16, and another 34% in females that were jabbed with the HPV vaccine between 16 to 18.

This new study, which was funded by the Cancer Research UK, researched all diagnosed cervical cancers in England in women between the ages of 20 to 64 and between the months of January 2006 and June 2019.

The study focused on women that were vaccinated with Cervarix between the ages of 12 to 13, 14 to 16, and 16 to 18 respectively. This allowed the researchers to separately record incidences of cervical cancer and non-invasive cervical carcinoma (CIN3) with the seven populations.

Back in England, the vaccine program began in the year 2008 during the time the bivalent vaccine, Cervarix, was being used. Notably, this particular vaccine is known to protect against two of the most common types of HPV. By September 2012, the quadrivalent vaccine, Gardasil, has been used instead of Cervarix.

With most cervical cancers being caused by HPV, the vaccine is said to be most effective in individuals when they receive the jab before they become sexually active – which is when it’s most unlikely that they have been exposed to HPV. Moreover, the human papillomavirus is also linked with other types of cancer such as vulvar, vaginal, penile, anal, and some head and neck cancers as well.

According to Consultant Epidemiologist in Immunizations at Public Health England, Dr. Vanessa Saliba, “These remarkable findings confirm that the HPV vaccine saves lives by dramatically reducing cervical cancer rates among women. This reminds us that vaccines are one of the most important tools we have to help us live longer, healthier lives.”

“Assuming most people continue to get the HPV vaccine and go for screening, cervical cancer will become a rare disease. This year we have already seen the power of vaccines in controlling the COVID-19 pandemic. These data show that vaccination works in preventing some cancers,” she added.

“This fantastic achievement has been made possible thanks to the high uptake of the HPV vaccine in England. We encourage all who are eligible for the HPV vaccine to take it up when it is offered in school. All those eligible can catch-up until their 25th birthday. Together with cervical screening, this will help to protect more women from preventable cases of cervical cancer,” she concluded.

To learn more about this groundbreaking study, you can see the published work in the Lancet journal.